SCHEMBL4852334

SCHEMBL4852334

COc1c(F)cc2c(c1Cl)CCC2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
TUBB4A P04350 3/20 0.34
TUBB P07437 3/20 0.34
TUBA3C P0DPH7 3/20 0.34
TUBA1B P68363 3/20 0.34
TUBA4A P68366 3/20 0.34
TUBB4B P68371 3/20 0.34
TUBB3 Q13509 3/20 0.34
TUBB2A Q13885 3/20 0.34
TUBB8 Q3ZCM7 3/20 0.34
TUBA3E Q6PEY2 3/20 0.34
TUBA1A Q71U36 3/20 0.34
TUBA1C Q9BQE3 3/20 0.34
TUBB6 Q9BUF5 3/20 0.34
TUBB2B Q9BVA1 3/20 0.34
TUBB1 Q9H4B7 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3967795 0.82 KDM4E (0.54) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL31674081 0.80 KDM4E (0.51) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL31673942 0.77 KDM4E (0.45) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL10748376 0.75 ALDH1A1 (0.42) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL32669252 0.75 NOTUM (0.32) NOTUM
SCHEMBL11115887 0.75 KDM4E (0.49) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL24362559 0.74 ALDH1A1 (0.38) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL20234384 0.74 BRD4 (0.41) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL10754944 0.74 DRD2 (0.39) KDM4EALDH1A1HPGDGAAPTGS2
SCHEMBL31674038 0.73 KDM4E (0.69) KDM4EALDH1A1HPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-7432284-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2008-10-07 US disclosed
US-20060041003-A1 Estrogen receptor modulators MERCK SHARP & DOHME LLC 2006-02-23 US disclosed
EP-1551820-A2 ESTROGEN RECEPTOR MODULATORS Merck & Co., Inc. (US) 2005-07-13 EP disclosed
WO-2004026887-A2 ESTROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041003-A1 Estrogen receptor modulators GPER1, ESR2, ESR1 KDM4E 1225/4885ALDH1A1 1646/4885HPGD 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.